AnGes MG, Inc.
AnGes MG, Inc. is named on 0 US grants and 9 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 0
- Published applications
- 9
- Inventors
- 19
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
By publication year.
Technology areas
Share of 9 documents
Recent patents
No granted patents yet.
- Gene therapy for diabetic ischemic disease24 Feb 2011US 2011/0045061 A1
- Agent for regulating bone formation9 Dec 2010US 2010/0311823 A1
- Pharmaceutical composition containing decoy and method of using the same23 Apr 2009US 2009/0105183 A1
- Agent for Regulating Bone Formation18 Dec 2008US 2008/0312145 A1
- Agents for gene therapy of cerebrovascular disorders4 Sep 2008US 2008/0213348 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.